Methamphetamine Induces TET1- and TET3-Dependent DNA Hydroxymethylation of Crh and Avp Genes in the Rat Nucleus Accumbens by Jayanthi, Subramaniam et al.
Methamphetamine Induces TET1- and TET3-Dependent DNA
Hydroxymethylation of Crh and Avp Genes in the Rat
Nucleus Accumbens
Subramaniam Jayanthi1 & Betina Gonzalez2 & Michael T. McCoy1 & Bruce Ladenheim1 &
Veronica Bisagno2 & Jean Lud Cadet1,3
Received: 5 June 2017 /Accepted: 15 August 2017
# The Author(s) 2017. This article is an open access publication
Abstract Methamphetamine (METH) addiction is a
biopsychosocial disorder that is accompanied by multiple re-
lapses even after prolonged abstinence, suggesting the possi-
bilities of long-lasting maladaptive epigenetic changes in the
brain. Here, we show that METH administration produced
time-dependent increases in the expression of corticotropin-
releasing hormone (Crh/Crf), arginine vasopressin (Avp), and
cocaine- and amphetamine-regulated transcr ipt
prepropeptide (Cartpt) mRNAs in the rat nucleus accumbens
(NAc). Chromatin immunoprecipitation (ChIP) assays re-
vealed thatMETH increased the abundance of phosphorylated
CREB (pCREB) at the promoter of Cartpt but not at Avp or
Crh DNA sequences. In contrast, METH produced DNA hy-
pomethylation at sites near the Crh transcription start site
(TSS) and at intragenic Avp sequences. METH also increased
DNA hydroxymethylation at the Crh TSS and at intragenic
Avp sites. In addition, METH increased the protein expression
of ten-eleven-translocation enzymes that catalyze DNA
hydroxymethylation. Importantly, METH increased TET1
binding at the Crh promoter and increased TET3 binding at
Avp intragenic regions. We further tested the role of TET en-
zymes inMETH-induced changes in gene expression by using
the TET inhibitor, 1,5-isoquinolinediol (IQD), and found that
IQD blocked METH-induced increases in Crh and Avp
mRNA expression. Together, these results indicate that
METH produced changes in neuropeptide transcription by
both activation of the cAMP/CREB pathway and stimulation
of TET-dependent DNA hydroxymethylation. These results
provide molecular evidence for epigenetic controls of
METH-induced changes in the expression of neuropeptides.
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Introduction
Methamphetamine (METH) is an addictive psychostimulant
whose abuse is widespread throughout the world. Similar to
other psychostimulants, its rewarding properties are due to
activation of the reward pathway that projects from the ventral
tegmental area (VTA) to diverse brain structures including the
nucleus accumbens (NAc) [1, 2]. Perturbations in this path-
way may be involved in promoting relapses [3]. Importantly,
because some neurotransmitters may be regulators of various
addiction stages that include initiation, escalation, and recur-
rent relapses [4], pharmacological manipulations of these
brain systems may offer opportunities to treat addiction [5,
6]. In fact, addiction appears to stimulate diverse pathways
that may serve as a coincident signal to promote compulsive
drug-taking behaviors [7, 8]. Some of these pathways may use
neuropeptides that are known to respond to stress, as recently
described in a microarray paper that documented METH-
induced increases in the expression of Crh/Crf, Avp, and
Cartpt in the NAc [8]. These peptides are known participants
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in stress responses in several brain regions [9, 10]. Indeed, the
NAc is known to be activated by stress [11], possibly through
the regulation of CRF since CRF-containing cell bodies are
located in that structure [12, 13].
Exposure to psychostimulants has now been shown to result
in epigenetic modifications in several regions of the brain [8, 14].
These epigenetic events include covalent histone modifications,
DNAmethylation, and expression of non-codingRNAs [15, 16].
Although most of these studies have investigated the effects of
cocaine, a few reports have begun to identify a role for epigenetic
mechanisms in METH-induced changes in the brain. For exam-
ple, Ikegami et al. (2010) [17] showed that METH increased
methylation of histone H3 at lysine 4 (H3K4me3) in the NAc.
METH also produced differential effects on histone acetylation
in the NAc, decreased histone deacetylase HDAC1 protein
levels, and increased HDAC2 expression [18]. METH-induced
conditioned place preference (CPP) increased histone H3 di- and
trimethylation at lysine 4 (H3K4me2 and me3) but decreased
H3K27me2 abundance [19]. Moreover, METH increased the
expression of the DNA methyltransferase, DNMT1 [20, 21].
Interestingly, parental METH exposure produced DNA hyper-
methylation at 70 loci but DNAhypomethylation at 39 loci in the
hippocampus of F1 mice [22]. More recently, we have shown
that abstinence from METH SA is associated with increased
hydroxymethylation in a subgroup of rats [23]. Taken together,
these observations support the notion that METH may signifi-
cantly alter biochemical pathways and behaviors via diverse epi-
genetic mechanisms including DNA methylation/demethylation
processes.
DNA hypermethylation of cytosines adjacent to guanines
(CpG sites) is thought to be responsible for transcription repres-
sion while DNA hypomethylation is more often associated with
increased gene expression [24]. Demethylation is generated by
the oxidat ion of 5-methylcy tos ine (5mC) to 5-
hydroxymethylcytosine (5hmC) by ten-eleven translocation pro-
teins [25] and by TET-dependent generation of 5-formylcytosine
and carboxylcytosine followed by action of thymine-DNA
glycosylase and base excision repair (BER) [26]. 5hmC is highly
enriched in the adult brain [27] and appears to play a crucial role
in the establishment of epigenetic states that promote gene ex-
pression and rapid behavioral adaptation [28].
As mentioned above, studies focusing on epigenetic neural
adaptations in the NAc are important because that structure is an
important link in the pathways that subsume drug-induced be-
havioral phenomena [29–31] including relapse [32]. Here, we
report that METH increased Crh and Avp mRNA levels via
increasing DNA hydroxymethylation around the Crh TSS and
in Avp intragenic regions in the NAc. We found, in addition, that
Crh TSS hydroxymethylation is mediated by TET1 while Avp
hydroxymethylation is secondary to the actions of TET3. In con-
trast, METH-induced changes inCartpt expression are mediated
by increased binding of phosphorylated CREB (pCREB) at the
Cartpt promoter. Together, these results support the notion that
METH can produce a diversity of epigenetic changes in the NAc
and identify DNAhydroxymethylation as a potentially important
target for the development of anti-addictive drugs.
Methods and Materials
Animals and Drug Treatment
All animal treatments and procedures were approved by the
National Institute of Drug Abuse Animal Care and Use
Committee according to the Guide for the Care and Use of
Laboratory Animals (ISBN 0-309-05377-3). Male Sprague-
Dawley rats, 8–10 weeks old (Charles River Labs, Raleigh),
weighing 250–300 g were housed in a humidity- and
temperature-controlled (22.2 ± 0.2 °C) room with free access to
food and water. The rats were group-housed (two rats per cage)
with the regular light/dark schedule. All animals acclimated to
the facility for 1 week. Following habituation, rats were random-
ly assigned to two groups (12 rats per group for each time point)
and received intraperitoneal (i.p.) injections of saline or METH
(10mg/kg). This is a non-blinded study. To study the time-course
effect of theMETH injection, animals were euthanized at 1, 2, 3,
or 4 weeks after the saline or drug injection. The euthanization
procedure was completed at a consistent time of the day. NAc
tissues were dissected and immediately frozen to be used in RT-
qPCR, western blot analysis, methylcytosine DNA immunopre-
cipitation (MeDIP), and hydroxyMeDIP (hMeDIP) assays. For
ChIP, MeDIP, and hMeDIP experiments, the NAc tissues were
processed as described below.
For co-treatment with TET inhibitor, rats received an initial
1,5-isoquinolinediol (IQD) (3 mg/kg dissolved in DMSO,
Santacruz) i.p. injection 4 h prior to either saline or to METH
injections on day 1. Subsequently, IQDwas injected on days 2, 4,
and 6 days after the METH injection. During subsequent weeks
(2nd, 3rd, and 4th week), two injections of IQD were given per
week. The administered IQD dose was according to the pub-
lished literature [33, 34]. This dose schedule resulted in four
experimental groups (eight rats in each group): saline/saline
(control); saline/METH; IQD (3 mg/kg)/saline (IQD + saline);
IQD (3 mg/kg)/METH (IQD + METH).
Quantitative PCR Analysis of mRNA Levels
Total RNA was isolated from one NAc hemisphere using
RNeasy Mini kit (Qiagen) (n = 8–12 rats per group). Unpooled
total RNA (0.5 μg) isolated from NAc samples was reverse-
transcribed with oligo dT primers using Advantage RT-for-
PCR kit (Clontech). RT-qPCR was performed essentially as de-
scribed previously [18, 35] with Roche LightCycler 480 II
(Roche Diagnostics) using iQ SYBR Green Supermix
(BioRad). For all RT-qPCR experiments, individual data were
normalized using the corresponding 18S mRNA level. The
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results are reported as fold changes calculated as the ratios of
normalized gene expression data for METH-treated groups (at
various time points) in comparison to the control group (SS).
Primers for Crh (forward sequence 5′-CCT CGC AGA ACA
GTG-3′ and reverse sequence 5′-CCT CAG AAG GTG GAA
GGT G-3′), Crhr1 (forward sequence-5′-GTC CCT GAC CAG
CAATGTTT-3′ and reverse sequence-5′-CGGAGT TTGGTC
ATGAGGAT-3′),Crhr2 (forward sequence-5′-AAGGTCCTA
GGA GTG ATC CGA TT-3′ and reverse sequence-5′-GGA
GCC ACC AGA GAG TGC AG-3′), Avp (forward sequence-
5′-GAG TGT CGA GAG GGT TT-3′ and reverse sequence-5′-
GGCGATGGCTCAGTAGA-3′), Avpr1a (forward sequence-
5′-CGT GGG TCC CTT TCA TA-3′ and reverse sequence-5′-
GAA ATT CTC ATC CCA GAC T-3′), Avpr1b (forward se-
quence-5′-GGC CTA CAT CAC CTG GA-3′ and reverse se-
quence-5′-GCA GAA GAT GAG GAC TTAT-3′), and Cartpt
(forward sequence-5′-TGG GAA GAA GAG GGA CT-3′ and
reverse sequence-5′-TAATTTGCACATGCT TCCA-3′) were
synthesized at the Synthesis and Sequencing Facility of Johns
Hopkins University (Baltimore, MD).
Immunoblot Analysis
Western blot analyses were carried out from NAc protein lysates
(n = 6 rats per group). Samples were homogenized separately in
10% w/v of ice-cold 10 mM HEPES buffer (pH 7.4) containing
10 mM KCl, 1.5 mMMgCl2, 1%-Igepal CA-630 supplemented
with a Roche protease inhibitor cocktail tablet (Roche
Diagnostics). The homogenate was centrifuged for 5 min at
1400 × g to pellet nuclear fraction. The nuclear fraction was re-
suspended in a nuclear lysis buffer (20 mM HEPES, 25% glyc-
erol, 840 mM NaCl, 1.5 mM MgCl2, 0.4 mM EDTA). The
supernatant was the cytosolic fraction. Protein concentrations of
the nuclear fractions were determined by a BCA assay
(ThermoFisher Scientific) and were then denatured with sample
buffer (62.5 mM Tris-HCl, 10% glycerol, 2% SDS, 0.1%
bromophenol blue, and 50 mM DTT) at 100 °C for 5 min and
subjected to SDS-PAGE. Proteins were electrophoretically trans-
ferred to Hybond-PVDF membrane (Amersham). Subsequently,
the membranes were incubated overnight at 4 °C with specific
antibodies against CREB and pCREB (Cell Signaling, #9197
and #9191), DNMT1 (Abcam, ab54759), DNMT3A,
DNMT3B (Cell Signaling, #3598 and #2161), TET1, TET2,
and TET3 (Santa Cruz, sc163443, sc136926, and sc139186).
After incubation, the blots were washed with TBS containing
0.1% Tween-20. The membranes were then incubated with
HRP-conjugated anti-rabbit, anti-mouse, or anti-goat secondary
antibody for 1 h at room temperature. To confirm equal protein
loading, the blots were reprobed with α-tubulin antibody
(1:4000, 2 h at room temperature; Sigma). ECL plus chemilumi-
nescent reagents (GE Healthcare) were used to detect protein
expression. Signal intensity was measured with Carestream
Molecular Imaging software. Experiments were done twice.
Chromatin Immunoprecipitation Assay
NAc tissue was rapidly removed from rat brains (n = 8–10 rats
per group), minced to ~ 1-mm-sized pieces, and immediately
cross-linked in 1% formaldehyde for 15 min at room tempera-
ture. The cross-linking reactionwas stopped by adding glycine to
a final concentration of 0.125 M. The tissue was washed five
times in cold PBS containing a Roche protease inhibitor cocktail
tablet (Roche Diagnostics) and 1 mM PMSF (Sigma). Tissues
were then rapidly frozen on dry ice. The fixed NAc tissues were
suspended in SDS lysis buffer (Millipore) containing the Roche
protease inhibitor cocktail (RocheDiagnostics) and 1mMPMSF
and homogenized twice for 10 s. Each sample was transferred to
TPX plastic tube (Diagenode) and sonicated (15 cycles, 30″ ON
and 30″ OFF) using the Diagenode Bioruptor device.
Afterwards, fragmentation was checked by gel analysis to con-
firm a sheared range of 300–600 bp. Dynabeads (Life
Technologies) were incubated with 5 μg of ChIP antibodies di-
rected against pCREB (Cell Signaling, #9191), TET1
(ActiveMotif, #61443), TET2 (Millipore, MABE462), and
TET3 (Santa Cruz, sc139186). As a control, NAc tissues were
also incubated with 5 μg nonimmune rabbit IgG (Millipore, 12–
370) overnight at 4 °C.
Equal amounts of chromatin lysate (60 μg) were diluted with
ChIP dilution buffer (Millipore) to a final volume of 1.5 mL, and
100 μL of the pre-immunoprecipitated lysate was saved as Bin-
put^ for later normalization. The chromatin lysate was then
immunoprecipitated with appropriate antibodies overnight at
4 °C. The beads were sequentially washed once with low salt,
high salt, LiCl, and Tris-EDTA according to the manufacturer’s
instructions. The DNA-protein complexes were then eluted from
the beads with 500 μL of NaHCO3/SDS elution buffer. DNA
and proteins were dissociated at 65 °C for 4 h under high-salt
conditions, followed by RNase A treatment for 30 min at 37 °C
and proteinase K treatment for 1 h at 55 °C. The DNAwas then
extracted with phenol/chloroform, precipitated with ethanol, and
finally resuspended in 80 μL of 10 mM Tris pH 8.0.
qPCR was performed with ChIP specific primers for Crh,
Avp, and Cartpt (see Table S1 for details), using Roche
LightCycler (Roche Diagnostics) and with iQ SYBR Green
(BioRad) monitoring. All PCR reactions were performed in du-
plicate and included negative controls (no DNA). LightCycler
software was used to calculate standard curves calculated using
serial dilutions (100–0.1 ng) of input genomic DNA.
Methylated DNA Immunoprecipitation
and Hydroxymethylated DNA Immunoprecipitation
Genomic DNA was isolated from NAc tissue (n = 10 rats per
group) by overnight proteinase k treatment, phenol-chloroform
extraction, ethanol precipitation, and RNase digestion.
Subsequently, 300 μL fractions of DNA (20 μg) were sheared
by ultrasonic treatment using theDiagenode Bioruptor (12 cycles,
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30 s BON^, 30 s BOFF^) to obtain a fragment size between
~ 200–600 bp. After denaturation (10 min at 95 °C), 5 μg
DNA was then immunoprecipitated overnight at 4 °C using
5 μL of mouse monoclonal anti-5mC antibody (Millipore,
MABE146) for MeDIP assay or 5 μL of rabbit polyclonal anti-
5hmC antibody (ActiveMotif, #39769) for hMeDIP assay in a
final volume of 500 μL IP buffer (10 mM sodium phosphate (pH
7.0), 140 mM NaCl, 0.05% Triton X-100). We incubated the
mixture with 80 μL of Dynabeads (Life Technologies) overnight
at 4 °C and washed it three times with 700 μL of IP buffer. We
then treated the beads with proteinase K for 3 h at 50 °C and
recovered themethylated or hydroxymethylatedDNAby phenol-
chloroform extraction followed by ethanol precipitation. Sheared
Binput^ DNA samples were collected prior to immunoprecipita-
tion for subsequent comparison with immunoprecipitated DNA.
qPCR on MeDIP and hMeDIP Samples
We carried out qPCR reactions with 20 ng of input DNA
and immunoprecipitated methylated or hydroxymethylated
DNA. For qPCR reactions, we used the iQ SYBR Green
PCR master mix (BioRad) and Roche thermal cycler
(Roche Diagnostics). The primer sequences and location
are shown in Table S1. Reactions were done in duplicates
and standard curves were calculated on serial dilutions
(100–0.1 ng) of input genomic DNA. To evaluate the rel-
ative enrichment of target sequences after MeDIP or
hMeDIP, we calculated the ratios of the signals in the
immunoprecipitated DNA versus input DNA.
Statistical Analysis
All the quantitative data are presented as mean + SEM. For
time-course data comparing control and METH-treated
groups at various time points, as well as for the experiment
involving IQD (TET inhibitor co-treatment) and one-way
ANOVA followed by Fisher’s PLSD, post hoc analysis was
used to calculate significance for MeDIP, hMeDIP, and ChIP
experiments, the data were assessed by unpaired Student’s t
test (Stat View version 4.02). For all experiments, the null
hypothesis was rejected at p < 0.05.
Results
METH Causes Long-Lasting Increases in Gene
Expression of Crh, Avp, and Cartpt Neuropeptides
Injection of METH (10 mg/kg) produced substantial changes in
gene expression in rats euthanized 1 month later, with 338 genes
being upregulated and 165 being downregulated (Fig. 1a).
Among these genes were stress-relatedCrh, Avp, andCartpt that
showed increased expression [36] (Fig. 1b). Tomeasure potential
METH-induced time-dependent changes inCrh,Avp, andCartpt
mRNA levels, we injected the rats with either saline or METH
and euthanized the animals at 1, 2, 3, or 4 weeks after the saline
or METH injection. Figure 1 shows the time course of Crh (Fig.
1c), Avp (Fig. 1d), and Cartpt (Fig. 1e) expression after the drug
injection. METH caused time-dependent increases in the mRNA
levels of all three genes. The increases in the expression of Crh
[F(4,47) = 4.837, p = 0.0024] and Cartpt injection
[F(4,51) = 2.727, p = 0.0392] were apparent after 2 weeks and
remained elevated for the duration of the study (Fig. 1c and e).
METH-induced increases in Avp expression were significant at 3
and 4 weeks after the injection [F(4,44) = 4.577, p = 0.0035]
(Fig. 1d). We also measured mRNA levels of Crh and Avp re-
ceptors. Supplemental Fig. S1 shows these results. Crhr1
[F(4,48) = 4.134, p = 0.0059], Crhr2 [F(4,42) = 4.892,
p = 0.0025], and Avpr1a [F(4,45) = 4.213, p = 0.0056] mRNA
levels showed significant increases whereas Avpr1b
[F(4,53) = 2.571, p = 0.0483] showed significant decrease at 1
and 4 weeks after METH injection (Fig. S1).
METH Increases Enrichment of pCREB on Cartpt Gene
Promoter
Psychostimulant-induced changes in gene expression are me-
diated, in part, by a dopamine-cAMP-CREB (Cyclic AMP
Response Element-Binding) pathway that involves CREB
phosphorylation [37, 38]. CREB is also involved in regulating
stress-induced gene expression [7]. We thus wondered if the
injection of METH might increase phosphorylated CREB
(pCREB) in a time-dependent fashion. To test this idea, we
used specific antibodies to measure CREB and pCREB pro-
tein abundance and found no changes in CREB protein levels
(Fig. 2a) but time-dependent increases in pCREB abundance
in NAc nuclear fractions (Fig. 2b). The initial increase in
pCREB abundance was apparent by 1 week (~ 1.7-fold) and
reached 2.5-fold after 4 weeks injection [F(4,20) = 7.019,
p = 0.0011]. We next tested if METH might increase
pCREB recruitment onto Crh, Avp, and Cartpt CRE DNA
sequences by performing ChIP-qPCR assays. Figure 2c illus-
trates that METH increased pCREB binding on the Cartpt
gene promoter region but not on Crh or Avp CRE DNA se-
quences (see Table S1 for primer details).
DNA Methylation and Hydroxymethylation Regulate
METH-Induced Expression of Crh and Avp
Because pCREB did not appear to play a role in Crh and Avp
mRNA expression, we wondered if METH-induced DNA hy-
pomethylation might be involved in the upregulation of these
mRNAs. Analysis of METH-induced effects on DNA methyla-
tion status of the Crh and Avp genes by using MeDIP-qPCR
assays revealed significant METH-induced DNA hypomethyla-
tion at the Crh promoter region [t = 2.209, p = 0.049] (Fig. 3a)
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and at a CpG-rich region within the Avp gene body [t = 2.615,
p = 0.024] (Fig. 3b). However, when we measured the protein
expression of DNA methyltransferases (DNMT1, DNMT3A,
and DNMT3B) [39], we found that METH increased the protein
expression of DNMT1 [F(4,20) = 35.897, p< 0.0001] but not the
expression of DNMT3A and DNMT3B (Fig. 4a–c). Although
these results are consistent with previous findings showing
METH-induced increases in DNMT1 [20, 21], they suggested
that the METH-induced DNA hypomethylation was most likely
not secondary to decreased DNMT expression but probably to
TET-induced DNA hydroxymethylation. TET proteins convert
5mC to 5hmC and 5fC (5-formyl cytosine) and 5caC (5-carboxyl
cytosine) [25]. DNA hydroxymethylation is also known to be a
stable epigenetic mark that regulates gene expression [40, 41].
We thus tested the possibility that METH might cause increased
DNA hydroxymethylation in the Nac. We indeed detected drug-
induced increased hMeDIP enrichment at the Crh TSS
[t = − 5.618, p < 0.0001] and the Avp intragenic region
[t = − 3.509, p = 0.0038] (Fig. 3c and d).
TET Proteins Mediate METH-Induced Alterations
in DNA Hydroxymethylation
To tes t i f TET prote ins were involved in DNA
hydroxymethylation, we measured TET1, TET2, and TET3 pro-
tein levels in nuclear fractions obtained from theNAc. Therewere
significant time-dependent increases in TET1 and TET3 protein
levels in the NAc after METH, with TET1 reaching 3.8-fold
[F(4,20) = 9.055, p = 0.0005] (Fig. 5a) and TET3 reaching 2.5-
fold increases [F(4,20) = 27.245, p < 0.0001] (Fig. 5c). TET2
expression only reached 1.4-fold [F(4,20) = 2.429, p = 0.0815]
increases (Fig. 5b).
To further investigate the role of TET proteins in METH-







Avp arginine vasopressin 10.84
Avpr1a arginine vasopressin receptor 
1A
8.12
Cartpt cocaine and amphetamine 
regulated transcript
5.65
Crh corticotrophin releasing 
hormone
4.00
a bFig. 1 a Rats were treated with
saline or METH (10 mg/kg), and
microarray analyses (n = 6 rats per
group) were performed 30 days
later. The microarray data has
been deposited in the NCBI
database: GEO accession number
GSE46717. b List of stress-
related neuropeptide genes whose
mRNAwas significantly
increased (greater than + 1.8-fold,
p < 0.01) include Avp (10.8-fold),
Avpr1a (8.12-fold), Cartpt (5.65-
fold), and Crh (4-fold). METH
produces time-dependent
increased expression of c Crh, d
Avp, and e Cartpt. Total RNAwas
extracted from the NAc (n = 8–12
rats per group), and quantitative
PCR forCrh, Avp, andCartptwas
carried out as described in the
text. The relative amounts of
mRNAwere normalized to 18S
and quantified. Values represent
means ± SEM of fold changes
relative to the controls. Analysis
of variance (ANOVA) followed
by Fisher’s PLSD (protected least
significance difference) was used
to determine statistical
significance. Key to statistics:
*p < 0.05; **p < 0.01; and
***p < 0.001, in comparison to
the control group
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specific antibodies against the TET proteins to measure TET
binding to Avp and Crh (Fig. 5d–i). We found significant
METH-induced increased enrichment of TET1 on the Crh pro-
moter sequence [t = − 2.500, p = 0.0245] (Fig. 5d) and increased
enrichment of TET3 on Avp intragenic CpG-rich site
[t = − 2.228, p = 0.0428] (Fig. 5i). There were neither significant
changes in TET2 (Fig. 5e) and TET3 (Fig. 5f) binding at theCrh
promoter nor in TET1 (Fig. 5g) and TET2 (Fig. 5h) binding at
the Avp intragenic site.
So far, our observations had indicated that METH increased
Crh and Avp expression by TET-dependent DNA
hydroxymethylation. To further test the role of TET in this pro-
cess, we used the TET inhibitor, IQD [34], that prevents DNA
demethylation and the accumulation of TET-induced DNA inter-
mediates [33]. IQD alone did not influence Crh and Avp expres-
sion. However, IQD co-treatment with the psychostimulant
significantly blocked METH-induced increased Crh (Fig. 5j)
and Avp (Fig. 5k) mRNA levels.
Discussion
The present study shows that an injection of METH pro-
duced long-lasting alterations in the expression of Crh,
Avp, and Cartpt mRNAs. These neuropeptides are in-
volved in a diversity of neuroendocrine responses to
stressful events [5, 42]. These results are consistent with
the observations that a single injection of amphetamine
(AMPH) can cause hypersecretion of plasma adrenocorti-
cotropin hormone (ACTH) and corticosterone measured at
1 and 3 weeks [43]. We show, in addition, that METH
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Fig. 2 METH increased CREB phosphorylation and pCREB abundance
at the Cartpt gene promoter. Western blot analyses (n = 6 rats per group)
revealed no METH-induced changes in a CREB protein levels but
significant time-dependent increases in the abundance of b pCREB.
Representative photomicrographs show results of three samples per
time point. For quantification, the signal intensity was normalized to α-
tubulin. Values represent means ± SEM of fold changes relative to the
controls. Statistical analysis was performed as in Fig. 1. Key to statistics:
*p < 0.05; **p < 0.01; and ***p < 0.001 in comparison to the control
group. For ChIP assays, we used animals euthanized at the 30-day time
points. ChIP assays were performed using an anti-pCREB (cell
signaling), and quantitative PCR was performed as described in the text
using specific ChIP primers directed at Crh, Avp, or Cartpt c promoter
regions. d Primers used for PCR following ChIP using antibodies against
pCREB are pictured in dotted arrows and were designed so that resulting
PCR amplicons contain the corresponding CRE site. CRE site sequence:
TGACGTCA. In Avp promoter, the CRE site presents only half of the
binding sequence. CRE half-site sequence: CGTCA (see Table S1 for
primer sequences). Values represent means ± SEM of fold changes
relative to the controls. Unpaired Student’s t test was used for statistical
analyses. Key to statistics: *p < 0.05; **p < 0.01; and ***p < 0.001 in
comparison to the control group
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at Crh and Avp promoters. In contrast, METH caused
DNA hydroxymethylation at a CpG-rich region in the
promoter of the Crh gene and at a CpG-rich intragenic
site of the Avp gene. DNA hydroxymethylation is known
to be catalyzed by TET enzymes [25]. Consistent with this
fact, we also found that METH increased TET1 binding at
the Crh promoter and TET3 binding at the Avp intragenic
site. Importantly, TET inhibition with the drug, IQD,
blocked METH-induced Crh and Avp mRNA overexpres-
sion. Our findings are consistent with the demonstration
that METH-induced gene transcription is regulated by di-
verse epigenet ic mechanisms that include post-
translational histone modifications and DNA methylation
[18, 20, 22, 38, 44].
The present observations further implicate a role of stress-
related neuropeptides in the biochemical and molecular effects
of drugs of abuse, at least, in the NAc. For example, the ex-
pression of Crh, Avp, and Cart is increased in various brain
regions in response to a diversity of stressful events including
administration of psychostimulants [42, 45–47]. Our observa-
tions of increased NAc Crh expression after the METH
injection are consistent with previous studies that have report-
ed increased Crh in several brain regions after withdrawal of
several drugs of abuse [10, 48–50] including increased levels
in the amygdala after METHwithdrawal [51]. A potential role
of Crh in METH-induced molecular and behavioral changes
is supported by the fact that administration of CP-154-526, a
Crh receptor 1 antagonist, interferes with METH-induced re-
instatement of extinguished METH-seeking behavior [52]. In
addition to Crh, we also found increases in Avp and Cartpt
mRNA levels. Avp has previously been implicated in the ac-
quisition of cocaine-seeking behavior [53] and cocaine with-
drawal [54]. Cart peptide is also increased in reward-related
brain subregions following administration of various
psychostimulants [55–57]. Our results are also consistent with
the report of increased CartptmRNA in the NAc of victims of
cocaine overdose [58]. Increased Cartpt is thought to partici-
pate in the regulation of the biochemical effects of dopamine
in the NAc [55–57]. This suggestion is supported by behav-
ioral studies showing that injection of Cart peptide into the
NAc reduces the rewarding effects of cocaine [59] and blunts















Fig. 3 METH caused DNA hypomethylation (a and b) and increased
DNA hydroxymethylation (c and d) at CpG-rich sites near the promoter
of Crh and at CpG-rich Avp intragenic sites. For MeDIP and hMeDIP
assay, we used animals euthanized at the 30-day time point (n = 10 rats
per group). Antibodies directed against either 5mC (Millipore) or 5hmC
(ActivMotif) were used to precipitate methylated or hydroxymethylated
DNA. Relative enrichment of 5mC or 5hmC was calculated using real-
time PCRwith specific primers directed at the promoter region ofCrh and
at the intragenic Avp CpG rich site (+ 1.8Kb). e Primers used for MeDIP
and hMeDIP assay are pictured in dotted arrows (see Table S1 for primer
sequences). Values represent means ± SEM of fold enrichment relative to
controls. Statistical significance was determined by unpaired Student’s t
test. Key to statistics: *p < 0.05; **p < 0.01 in comparison to the control
group
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Although the behavioral effects of these neuropeptides have
been well documented, the epigenetic mechanisms that con-
trol their expression remained to be clarified.
In this context, we first explore the potential role of
CREB phosphorylation in the METH-induced increases
in the expression of these genes because pCREB is known
to regulate psychostimulant-induced gene expression [38,
62]. Other studies have also implicated pCREB in the
regulation of Crh, Avp, and Cartpt expression [63–65].
Surprisingly, we found that pCREB binding was increased
only on the Cartpt promoter, indicating that METH had
increased Cartpt expression via the dopamine-PKA-
pCREB pathway in a manner consistent with a direct do-
paminergic input to Cart-peptide-containing neurons in
the NAc [66]. In addition to CREB phosphorylation, re-
cent studies have implicated DNA methylation in the reg-
ulation of Crh [67, 68] and of Avp [69] expression. The
latter reports are consistent with our demonstration of
METH-induced DNA hypomethylation on the Crh pro-
moter and at the CpG-rich region within the Avp gene
body. The drug-induced DNA hypomethylation is consis-
tent with our observations of METH-induced increased
DNA hydroxymethylation at the Crh and Avp DNA se-
q u e n c e s ( s e e F i g . 3 ) . I m p o r t a n t l y , D NA
hydroxymethylation is thought to drive transcription of
many genes [70, 71]. Hydroxymethylated DNA is very
abundant in the brain where it coordinates transcriptional
activity [27, 72]. Hydroxymethylcytosine (5hmC) is
found in gene bodies and at intron-exon boundaries of
synaptic plasticity-related genes [71, 73, 74]. Together,
these facts suggest that this DNA marker may play an
important role in the long-term effects of psychostimulant
exposure including cocaine [75].
Our findings that METH increased TET1 binding on the
Crh promoter and TET3 binding on the Avp intragenic region
are of interest because they illustrate the possibility of differ-
ential binding of these enzymes at different loci of two genes
that are co-regulated by METH. These observations are con-
sistent with recent reports indicating that accumulation of
5hmC at promoter regions is driven by the actions of TET1
[76, 77] whereas intragenic of 5hmC is associated with the
presence of TET3 [28, 78]. For example, overexpression of
TET3 in mature olfactory neurons increased 5hmC levels in
gene bodies that positively correlated with increased transcrip-
tion [78]. Our pharmacological interventions with a TET in-
hibitor (IQD) that blocked the METH-induced changes in the
expression of both Crh and Avp, suggesting this agent may be
worth pursuing in animal models of addiction that includes
stress-induced relapse to drug seeking. This statement is con-
sistent with the report that IQD treatment can prevent impaired
recognition memorymeasured inmice that have been exposed
to a combination of stress and alcohol [79].
In summary, we have shown, for the first time, that
TET-dependent DNA hydroxymethylation is the main de-
terminant of Crh and Avp regulation in the rat NAc after
injection of METH. Our results also specify TET1 and
TET3 as the respective enzymes involved in the catalytic
steps that produce DNA hydroxymethylation at Crh and



















Fig. 4 METH causes time-dependent increased DNMT1 protein
expression. Western blot analyses (n = 6 rats per group) showed
significant time-dependent increases in the protein levels of a DNMT1
and no change in b DNMT3A and c DNMT3B. Representative
photomicrographs show results of three samples per time point. For
quantification, the signal intensity was normalized to α-tubulin. Values
represent means ± SEM of fold changes relative to the controls. Statistical
significance for the different time points was compared by analysis of
variance followed by Fisher’s PLSD. Key to statistics: *p < 0.05;
**p < 0.01; ***p < 0.001 vs. control group
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epigenetic mechanisms that link METH to neuropeptide
expression in the rat NAc. The scheme in Fig. 6 illustrates
these mechanisms. Furthermore, our demonstration that a
TET inhibitor can block the transcriptional effects of
METH indicates that such an approach may help to ex-
pand our armamentarium against METH addiction. This
suggestion will need to be tested by assessing if these
effects of METH can be expanded to self-administration
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METH
1wk 2wk 3wk 4wk
Con METH
1wk 2wk 3wk 4wk
ConMETH
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Con
Avp
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Fig. 5 TET1 and TET3 respectively regulate METH-induced DNA
hydroxymethylation at Crh and Avp DNA sequences (n = 8–10 rats per
group). Western blot analyses (n = 6 rats per group) revealed significant
METH-induced time-dependent changes in the protein levels of TET1 (a)
and TET3 (c). TET2 protein (b) levels were only increased at 4 weeks
after the METH injection. Representative photomicrographs show results
of three samples per group. For quantification, the signal intensity was
normalized to α-tubulin. Values represent means ± SEM of fold changes
relative to controls. ANOVA followed by Fisher’s PLSD was used to
detect significance level. Key to statistics: *p < 0.05; **p < 0.01;
***p < 0.001, in comparison to the control group. METH increased
enrichment of TET1 on the Crh gene promoter (d) but not on the Avp
intragenic site (g). There was, however, increased TET3 binding at the
Avp intragenic region but (i) not on the Crh promoter (f). TET2 binding
was not affected by METH (e, h). Values represent means ± SEM of fold
enrichment relative to the controls. Statistical significance was
determined by unpaired Student’s t test. Key to statistics: *p < 0.05, in
comparison to the control group. Co-treatment with TET protein
inhibitor, 1,5-isoquinolinediol (IQD) (n = 8 rats per group), blocked the
METH-induced increases in Crh (j) and Avp mRNA levels (k). Values
represent means ± SEM of fold changes relative to the controls.
Measurements of mRNA levels and statistical analysis are described in
Fig. 1. Key to statistics: *p < 0.05 vs. control group
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models of addiction. The role of other stress-responsive
systems including the extended amygdala will also need
to be investigated in future experiments.
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